Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/2244
Title: | Osteonecrosis of the mandible associated with bevacizumab therapy |
Authors: | SANTOS-SILVA, Alan Roger; ROSA, Giuliano Augusto Belizario; CASTRO JUNIOR, Gilberto de; DIAS, Reinaldo Brito; RIBEIRO, Ana Carolina Prado; BRANDAO, Thais Bianca |
Citation: | ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, v.115, n.6, p.E32-E36, 2013 |
Abstract: | Bevacizumab is a humanized antibody that blocks vascular endothelial growth factor and is of great value for the treatment of advanced cancer. Several adverse effects following its administration have been reported. To date, only 8 cases of osteonecrosis of the jaws associated with bevacizumab (without any association with bisphosphonates) have been reported. The aim of this article was to describe an original case of bevacizumab-related osteonecrosis of the jaw. A 61-year-old man diagnosed with advanced renal cell carcinoma was undergoing treatment with intravenous bevacizumab and temsirolimus when he spontaneously developed mandible osteonecrosis, which resolved after 3 months of conservative management. The present case reinforces recent speculation that the anti-angiogenic properties of bevacizumab may represent a potential new source of osteonecrosis of the jaws in patients undergoing cancer treatment. Multidisciplinary teams in cancer care should be aware of the possible association between osteonecrosis of the jaw and bevacizumab therapy. |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - HC/ICESP Artigos e Materiais de Revistas Científicas - LIM/24 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_CASTRO JUNIOR_Osteonecrosis_of_the_mandible_associated_with_bevacizumab_therapy_2013.PDF Restricted Access | publishedVersion (English) | 390.43 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.